Biotech

All Articles

2 cancer biotechs merge, generating international footprint

.OncoC4 is actually taking AcroImmune-- and also its internal scientific manufacturing abilities-- u...

Amgen files very first stage 3 gain for $400M dermatitis drug

.Amgen has discussed (PDF) the initial phase 3 records on its own $400 thousand dermatitis medicatio...

Biogen, UCB record stage 3 lupus win after failing earlier test

.Biogen as well as UCB's gamble on developing right into phase 3 on the back of an unsuccessful rese...

Aptadir wishes brand new RNA preventions can easily turn around tricky cancers cells

.Italian biotech Aptadir Therapeutics has introduced with the commitment that its own pipe of precli...

Wave surfs DMD effectiveness to regulators' doors, sending stock up

.Surge Life Sciences has actually satisfied its objective in a Duchenne muscular dystrophy (DMD) stu...

Sanofi plucks brand-new CSO from in-stealth biotech

.After a few years in biotech, Mike Quigley, Ph.D., is actually returning to the pharma layer, takin...

Achilles droplets tissue treatment plan, prepares for layoffs after overlooking 'business viability' goals

.Achilles Rehabs has wrecked its own strategy. The English biotech is knocking off on its clinical-p...

Aligos heralds phase 2 MASH gain, lowering liver fat approximately 46%

.Aligos Therapeutics is proclaiming a midstage win in metabolic-dysfunction associated steatohepatit...

Basilea ratings $268M BARDA funding for antifungals, antibiotics

.Basilea Pharmaceutica's job building brand-new antifungals has actually received a significant impr...

Capricor sells Europe liberties to late-stage DMD treatment for $35M

.Possessing already scooped up the united state civil liberties to Capricor Therapeutics' late-stage...